Core facilities provide faculty and students access to the newest instrumentation to advance their research. Texas Biologics is committed to investing in our multi-user facilities to support cross-campus biologics research efforts.
Our Investments
Histology Core
Texas Biologics is supporting the opening of a new Histology Core within the Center for Biomedical Research Support (CBRS). The Core will be housed at the Dell Pediatric Research Institute and will benefit researchers across campus. Texas Biologics is purchasing instrumentation upgrades for the facility to bring our capabilities to the technical forefront, including a cryostat and automated slide scanner. CBRS is currently hiring a skilled histologist to manage the facility and support UT researchers. The opening date of the facility has not yet been announced.
Histology services are used by researchers to study fundamental, clinical, and translational questions across a range of disciplines, including therapeutics development. The histology core will offer services that include sample processing, sectioning, staining and documenting of tissues.
Biorespository
In partnership with Dell Medical School’s Health Transformation Research Institute, Texas Biologics will support a new biorepository to collect biospecimens for laboratory research across campus. Through our joint Science Studio Program, Texas Biologics will first identify health areas of focus to inform UT researchers’ requirements for biospecimens. We expect the first specimens to be acquired after a one-year planning phase.
A biorepository provides a sustainable supply of high quality biospecimens to researchers and is essential for translational research. For example, samples can be used for prognostic and predictive biomarker discovery or to understand cell signaling pathways and identification of drug targets. Having a biorepository on UT's campus will accelerate the research of our faculty, clinicians, and students.
Future Plans
Texas Biologics is already planning for additional investments across UT. These investments may include a Biosafety Level – 3 Laboratory to conduct research on live, infectious pathogens and an updated Proteomics Core and new Metabolomics Core to advance precision medicine.
If you see a critical equipment need that would benefit researchers across UT, please contact us.
